WallStreetZenWallStreetZen

NASDAQ: CSBR
Champions Oncology Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CSBR

Based on 1 analyst offering 12 month price targets for Champions Oncology Inc

Min Forecast
$6.00+38.25%
Avg Forecast
$6.00+38.25%
Max Forecast
$6.00+38.25%

Should I buy or sell CSBR stock?

Based on 1 analyst offering ratings for Champions Oncology Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their CSBR stock forecasts and price targets.

CSBR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-09-12

1 of 1

Forecast return on equity

Is CSBR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is CSBR forecast to generate an efficient return on assets?

CSBR revenue growth forecast

How is CSBR forecast to perform vs Biotechnology companies and vs the US market?

Company
21.19%
Industry
253.87%
Market
8.61%
CSBR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CSBR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CSBR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CSBR$4.34$6.00+38.25%Buy
AADI$2.36$1.75-25.85%Hold
VOR$0.85$11.63+1,275.74%Strong Buy
ALVR$0.50N/AN/A
FBIO$2.06$26.00+1,165.21%Buy
View Top Biotech Stocks

Champions Oncology Stock Forecast FAQ

Is Champions Oncology Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: CSBR) stock is to Buy CSBR stock.

Out of 1 analyst, 0 (0%) are recommending CSBR as a Strong Buy, 1 (100%) are recommending CSBR as a Buy, 0 (0%) are recommending CSBR as a Hold, 0 (0%) are recommending CSBR as a Sell, and 0 (0%) are recommending CSBR as a Strong Sell.

If you're new to stock investing, here's how to buy Champions Oncology stock.

What is CSBR's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: CSBR) forecast ROE is N/A, which is considered weak.

What is CSBR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year CSBR price target, the average CSBR price target is $6.00, with the highest CSBR stock price forecast at $6.00 and the lowest CSBR stock price forecast at $6.00.

The Wall Street analyst predicted that Champions Oncology's share price could reach $6.00 by Sep 12, 2025. The average Champions Oncology stock price prediction forecasts a potential upside of 38.25% from the current CSBR share price of $4.34.

What is CSBR's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: CSBR) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 537.97%.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.